Rob is a member of the Advisory Board at apollo.vc
Rob Scott has over 30 years of leadership experience in drug discovery and development in the global pharmaceutical and biotechnology industries.
As the former Chief Medical Officer and Head of Development at AbbVie, he oversaw successful drug development teams responsible for brands like Norvasc, Lipitor, Repatha, Humira, Skyrizi, and Rinvoq.
Prior to AbbVie, he held the positions of Vice President, Global Development TA Head, and Head of Development Design Center at Amgen.
During his tenure from 2012 to 2016, Rob served as a member of the US FDA's Cardiovascular and Renal Drug Advisory Committee, establishing strong relationships with senior FDA staff.
Rob is a member of the Advisory Board at apollo.vc
Rob Scott has over 30 years of leadership experience in drug discovery and development in the global pharmaceutical and biotechnology industries.
As the former Chief Medical Officer and Head of Development at AbbVie, he oversaw successful drug development teams responsible for brands like Norvasc, Lipitor, Repatha, Humira, Skyrizi, and Rinvoq.
Prior to AbbVie, he held the positions of Vice President, Global Development TA Head, and Head of Development Design Center at Amgen.
During his tenure from 2012 to 2016, Rob served as a member of the US FDA's Cardiovascular and Renal Drug Advisory Committee, establishing strong relationships with senior FDA staff.
